Wednesday, June 29, 2022

GB Sciences Inc (OTCMKTS:GBLX) Higher Yields Paying Huge Dividends

GB Sciences Inc (OTCMKTS:GBLX) received a lot of attention last week as the company’s innovative technology led to higher cannabis growth yield, according to the company. Monday, GBLX was up another 20% but has since given some back, overall investor confidence remains high.  So what’s spurring this incredible run?
To recap, last month, it was reported that GBLX had exceeded the October gross revenue projection of $500K from the sale of premium flower by 2%. Gross sales projections for the month of November are also trending in this direction. GBLX’s cultivation facility has 180 active flower lights for plant cultivation and grows in a clean room-like environment. The industry standard yield is approximately one and one-half pounds yield per flower light (of cured, untrimmed flower). GB Sciences yield is about three pounds of yield per flower light. The COO Kevin Kuethe explained that the firm’s state-of-the-art modern growing facility and techniques help to support and control the growing environment enabling GBLX to consistently produce yields that are double the industry average.
GB Sciences Inc (OTCMKTS:GBLX) is a Las Vegas-based firm that frames itself as a company that focuses on the research and development of medical cannabis drugs and treatments.
GBLX claims to produce measurable medical-grade cannabis, cannabis concentrates, and cannabinoid therapies through using various technologies in plant biology, cultivation, and extraction techniques combined with biotechnology.
It also claims to be involved in the development of controlled-climate indoor agricultural technology growing and cultivation suites, including TissueBLOX, GrowBLOX, CureBLOX, and ExtractionLAB.
According to company materials, “GB Sciences, Inc. (GBLX) is a diverse cannabis company, focused on cultivation as well as biopharmaceutical research and development. The Company’s goal is creating safe, standardized, pharmaceutical-grade, cannabinoid therapies that target a variety of medical conditions.”
Find out when $GBLX stock reaches critical levels. Subscribe to Right Now by entering your Email in the box below.

Dr. Ulrich Reimann-Philipp, Chief Botanist at GBLX explained that the company’s tissue propagation initiative began in 2014 as a one-man project, and in that time, the company has been unwavering in its commitment to research and development, exploring and understanding the plant.
Tissue culture is an advanced method of propagating Cannabis. Tissue culture produces genetically identical offspring from a mother plant. The plants produced in this way can be considered identical twins.
The Cannabis tissue culture propagation is desirable as it generates many more (4 x +) offspring from the same mother plant as conventional cloning. Fewer mothers are needed, saving room, additional offshoot from a particular parent plant leads to having more inherently uniform batches which is vital for developing unvarying biological profiles in the harvested plants.
According to the company’s most recent release, “In light of the popular belief that commercial tissue propagation is an ‘urban myth’ in the Cannabis world, this announcement is a true breakthrough. This fact added to the consistently high crop yields and sharp monthly revenue increases over the past two months, is a pure innovation success story that is just beginning to emerge.”
Furthermore, Between 2016 and 2017, GBLX has increased its assets 5.5 times signifying the massive investment made within the last year. Its liquidity has also been boosted in a similar manner with non-current assets, with cash & short term assets rising from $35,000 to $2.69 million within a year. Cost of sales have also increased to $415,979 from $177,000 in the last year. It is expected that revenues for 2017 will be above the projected estimates.
Now trading at a market capitalization of $93.02M, GBLX  is an exciting story in the cannabis space and solid company to boot. We expect more news from the company soon and will be updating readers as more information comes out. Sign-up for continuing coverage on shares of $GBLX stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in $GBLX, either long or short, and we have not been compensated for this article.

Related Articles

Stay Connected


Latest Articles